Recro Pharma Inc

NASDAQ:REPH  
2.63
+0.30 (+12.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)91.76M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$17.1 Million
Adjusted EPS-$0.12
See more estimates
10-Day MA$2.59
50-Day MA$3.03
200-Day MA$2.87
See more pivots

Recro Pharma Inc Stock, NASDAQ:REPH

1 E Uwchlan Avenue, Suite 112, Exton, Pennsylvania 19341
United States of America
Phone: +1.484.395.2470
Number of Employees: 185

Description

Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The firm offers integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products. The company was founded by Geraldine A. Henwood and Thomas F. Henwood on November 15, 2007 and is headquartered in Exton, PA.